Hedge Fund - Perceptive Advisors
Iovance Biotherapeutics Inc. (IOVA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $97,392,643 | 2.17% | 11,979,415 | $5.23 |
| 2 | 2023 - Q3 (2023-09-30) | $54,431,367 | 1.81% | 11,962,938 | $6.53 |
| 3 | 2023 - Q2 (2023-06-30) | $98,816,326 | 2.86% | 14,036,410 | $7.16 |
| 4 | 2023 - Q1 (2023-03-31) | $93,725,780 | 2.76% | 15,339,735 | $6.90 |
| 5 | 2022 - Q4 (2022-12-31) | $63,719,674 | 1.78% | 9,971,780 | $7.81 |
| 6 | 2022 - Q3 (2022-09-30) | $98,181,000 | 2.84% | 10,248,624 | $11.53 |
| 7 | 2022 - Q2 (2022-06-30) | $130,562,000 | 4.08% | 11,826,299 | $13.10 |
| 8 | 2022 - Q1 (2022-03-31) | $203,150,000 | 4.06% | 12,201,261 | $15.46 |
| 9 | 2021 - Q4 (2021-12-31) | $193,342,000 | 2.97% | 10,127,941 | $22.02 |
| 10 | 2021 - Q3 (2021-09-30) | $283,337,000 | 4.11% | 11,489,772 | $23.56 |
| 11 | 2021 - Q2 (2021-06-30) | $285,173,000 | 3.7% | 10,959,772 | $25.99 |
| 12 | 2021 - Q1 (2021-03-31) | $273,915,000 | 3.46% | 8,651,785 | $41.45 |
| 13 | 2020 - Q4 (2020-12-31) | $425,316,000 | 4.56% | 9,166,304 | $39.70 |
| 14 | 2020 - Q3 (2020-09-30) | $332,019,000 | 4.84% | 10,085,632 | $30.66 |
| 15 | 2020 - Q2 (2020-06-30) | $324,170,000 | 5.25% | 11,809,494 | $32.88 |
| 16 | 2020 - Q1 (2020-03-31) | $349,343,000 | 9.09% | 11,670,057 | $26.51 |
| 17 | 2019 - Q4 (2019-12-31) | $260,640,000 | 5.17% | 9,416,202 | $22.75 |
| 18 | 2019 - Q3 (2019-09-30) | $200,467,000 | 5.4% | 11,014,702 | $22.11 |
| 19 | 2019 - Q2 (2019-06-30) | $292,158,000 | 6.7% | 11,915,127 | $15.06 |
| 20 | 2019 - Q1 (2019-03-31) | $116,362,000 | 3.28% | 12,235,811 | $9.71 |
| 21 | 2018 - Q4 (2018-12-31) | $108,333,000 | 4.12% | 12,241,111 | $9.64 |
| 22 | 2018 - Q3 (2018-09-30) | $82,014,000 | 2.19% | 7,290,199 | $14.19 |
| 23 | 2018 - Q2 (2018-06-30) | $74,908,000 | 1.96% | 5,852,202 | $14.62 |
| 24 | 2018 - Q1 (2018-03-31) | $104,141,000 | 2.91% | 6,162,202 | $15.14 |
| 25 | 2017 - Q4 (2017-12-31) | $38,208,000 | 1.26% | 4,776,114 | $8.03 |
| 26 | 2017 - Q3 (2017-09-30) | $36,627,000 | 1.39% | 4,726,114 | $6.33 |
| 27 | 2017 - Q2 (2017-06-30) | $32,068,000 | 1.61% | 4,363,114 | $6.36 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:100.0000 on 2013-09-26